News & Updates

Is it advisable to resume DOAC use 1 day after colorectal ESD?

14 Apr 2025 by

Resumption of direct oral anticoagulants (DOACs) a day after undergoing colorectal endoscopic submucosal dissection (ESD) results in fewer thromboembolic events without elevating the risk of delayed bleeding compared with 2 or 3 days after ESD, reports a study.

Is it advisable to resume DOAC use 1 day after colorectal ESD?

14 Apr 2025

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

13 Apr 2025

Coeliac disease may be safely diagnosed based on clinical features and endomysial antibody testing in low-risk adult patients, according to a study.

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

13 Apr 2025

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

12 Apr 2025 by

The health-related quality of life (QOL) trajectories for colorectal cancer (CRC) patients are largely similar, regardless of whether they received adjuvant chemotherapy, according to a study from Singapore. However, CRC patients who undergo adjuvant treatments commonly experience difficulties with functional recovery.

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

12 Apr 2025

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

Paediatric patients with autoinflammatory diseases undergoing treatment with canakinumab and tocilizumab can be safely vaccinated against hepatitis A, according to a prospective interventional study.

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

$G-POEM safe, effective for refractory gastroparesis$

G-POEM safe, effective for refractory gastroparesis

07 Apr 2025 by

A recent study has demonstrated the safety and efficacy of gastric per-oral endoscopic myotomy, or G-POEM, in the treatment of patients with refractory gastroparesis.

G-POEM safe, effective for refractory gastroparesis

07 Apr 2025

TTSS system closes gastrointestinal defects after endoscopy

05 Apr 2025

The recently approved through-the-scope suturing (TTSS) system demonstrates safety and efficacy in the closure of mucosal defects following therapeutic endoscopic interventions, reports a recent study.

TTSS system closes gastrointestinal defects after endoscopy

05 Apr 2025

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B

01 Apr 2025 by

In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B

01 Apr 2025

IBD patients at increased risk of intrahepatic cholestasis of pregnancy

28 Mar 2025

Pregnant women with inflammatory bowel disease (IBD), especially those with thiopurine exposure, face a heightened risk of intrahepatic cholestasis of pregnancy (ICP), according to the results of a systematic review and meta-analysis.

IBD patients at increased risk of intrahepatic cholestasis of pregnancy

28 Mar 2025

Diclofenac no better than indomethacin for preventing post-ECRP pancreatitis

26 Mar 2025

For patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), prophylactic administration of rectal diclofenac does not appear to significantly reduce the incidence of pancreatitis after the procedure when compared with rectal indomethacin, according to a study from China.

Diclofenac no better than indomethacin for preventing post-ECRP pancreatitis

26 Mar 2025

Neoadjuvant chemoimmunotherapy beneficial in locally advanced ESCC

26 Mar 2025

In the treatment of locally advanced esophageal squamous cell carcinoma (ESCC), neoadjuvant chemoimmunotherapy may prolong overall and disease-free survival compared with neoadjuvant chemoradiotherapy, according to a study from China.

Neoadjuvant chemoimmunotherapy beneficial in locally advanced ESCC

26 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Is it advisable to resume DOAC use 1 day after colorectal ESD?

Is it advisable to resume DOAC use 1 day after colorectal ESD?

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

Hepatitis A vaccine may be safely administered to children on biologic therapy

Hepatitis A vaccine may be safely administered to children on biologic therapy

G-POEM safe, effective for refractory gastroparesis

G-POEM safe, effective for refractory gastroparesis

TTSS system closes gastrointestinal defects after endoscopy

TTSS system closes gastrointestinal defects after endoscopy

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B

IBD patients at increased risk of intrahepatic cholestasis of pregnancy

IBD patients at increased risk of intrahepatic cholestasis of pregnancy

Diclofenac no better than indomethacin for preventing post-ECRP pancreatitis

Diclofenac no better than indomethacin for preventing post-ECRP pancreatitis

Neoadjuvant chemoimmunotherapy beneficial in locally advanced ESCC

Neoadjuvant chemoimmunotherapy beneficial in locally advanced ESCC